[1]
F. S. Vieira, “Drivers of federal spending in pharmaceuticals of the Specialized Component: measurement and analysis”, Rev. saúde pública, vol. 55, p. 91, Dec. 2021, doi: 10.11606/s1518-8787.2021055003097.